Cargando…
Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting
Apixaban and rivaroxaban are the two most prescribed direct factor Xa inhibitors. With the increased use of DOACs in real-world settings, safety and efficacy concerns have emerged, particularly regarding their concomitant use with other drugs. Increasing evidence highlights drug–drug interactions wi...
Autores principales: | Lenoir, Camille, Terrier, Jean, Gloor, Yvonne, Gosselin, Pauline, Daali, Youssef, Combescure, Christophe, Desmeules, Jules Alexandre, Samer, Caroline Flora, Reny, Jean-Luc, Rollason, Victoria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028714/ https://www.ncbi.nlm.nih.gov/pubmed/35455642 http://dx.doi.org/10.3390/jpm12040526 |
Ejemplares similares
-
Impact of SARS‐CoV‐2 Infection (COVID‐19) on Cytochromes P450 Activity Assessed by the Geneva Cocktail
por: Lenoir, Camille, et al.
Publicado: (2021) -
Population pharmacokinetics of apixaban in a real‐life hospitalized population from the OptimAT study
por: Gaspar, Frédéric, et al.
Publicado: (2023) -
Prediction of cytochromes P450 3A and 2C19 modulation by both inflammation and drug interactions using physiologically based pharmacokinetics
por: Lenoir, Camille, et al.
Publicado: (2021) -
Impact of Acute Inflammation on Cytochromes P450 Activity Assessed by the Geneva Cocktail
por: Lenoir, Camille, et al.
Publicado: (2021) -
CYP450 Genotype—Phenotype Concordance Using the Geneva Micrococktail in a Clinical Setting
por: Ing Lorenzini, Kuntheavy, et al.
Publicado: (2021)